Mode
Text Size
Log in / Sign up

Antimicrobial resistance drivers in human and agricultural sectors contribute to 4.95 million annual deathsAntimicrobial resistance linked to 4.95 million deaths in 2019

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize multi-sectoral drivers like poor sanitation and heavy metals as key contributors to global antimicrobial resistance.

This narrative review synthesizes the global burden and multi-sectoral drivers of antimicrobial resistance (AMR). It highlights that 4.95 million deaths were linked to AMR in 2019, with 3.57 million deaths directly attributable to drug-resistant infections. The review identifies Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus as major pathogens exhibiting alarming resistance to last-line antibiotics.

The authors identify several key drivers of AMR, including the overuse of antibiotics in healthcare and agriculture, poor sanitation, and exposure to biocides or heavy metals. These factors are linked to the genetic exchange of resistance determinants across human, livestock, and environmental interfaces. The review also identifies significant gaps in monitoring parameters and global surveillance, particularly in low- and middle-income countries.

Clinical implications focus on the need for integrated One Health surveillance and improved laboratory capacity. The authors emphasize antimicrobial stewardship (AMS) and wastewater monitoring as critical components of mitigation strategies. While specific trial data is not provided, the review highlights systemic gaps in current management practices.

How this fits prior evidence

This narrative review addresses a gap by identifying cross-sectoral drivers of AMR, including heavy metals and poor sanitation, which complements previous findings on how conjugation governs the spread of resistance genes across ecological compartments. It also supports the need for integrated antimicrobial stewardship strategies to control AMR worldwide, expanding upon the importance of maintaining gut microbiome integrity as a core component of such programs.

A new narrative review highlights the staggering global toll of antimicrobial resistance (AMR). In 2019, AMR was linked to 4.95 million deaths worldwide, with 3.57 million directly caused by drug-resistant infections. The review, which looked at human, livestock, agricultural, and environmental settings, identifies key drivers: overuse of antibiotics in healthcare and farming, poor sanitation, and the use of biocides and heavy metals. These factors allow bacteria to swap resistance genes, especially in low- and middle-income countries.

The review points to three major pathogens that are becoming resistant to last-line antibiotics: Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus. These infections are harder to treat, leading to more deaths. The authors stress that AMR is not just a human health issue but a cross-sectoral problem requiring a "One Health" approach.

Because this is a narrative review, it summarizes existing research rather than providing new clinical trial data. The findings are based on trends and gaps in surveillance, not controlled experiments. Still, the numbers are a stark reminder of the urgent need for better antibiotic stewardship, wastewater monitoring, and improved lab capacity, especially in regions with limited resources.

For readers, the takeaway is clear: antimicrobial resistance is a major global health threat that demands coordinated action. While the review doesn't offer personal medical advice, it underscores why you should use antibiotics only as prescribed and support efforts to reduce unnecessary use in agriculture.

What this means for you:
Antimicrobial resistance is a global crisis linked to millions of deaths, driven by antibiotic overuse and poor sanitation.

Common questions

How many deaths are linked to antimicrobial resistance?

In 2019, antimicrobial resistance was linked to 4.95 million deaths globally, with 3.57 million directly caused by drug-resistant infections.

What are the main drivers of antimicrobial resistance?

Key drivers include overuse of antibiotics in healthcare and agriculture, poor sanitation, and the use of biocides and heavy metals, which help bacteria share resistance genes.

Which bacteria are becoming resistant to last-line antibiotics?

Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus are major pathogens showing alarming resistance to last-line antibiotics.

What is a 'One Health' approach to antimicrobial resistance?

A One Health approach recognizes that human, animal, and environmental health are connected. It involves coordinated surveillance and stewardship across all sectors to fight AMR.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
BackgroundAntimicrobial resistance (AMR) poses a significant threat to global healthcare systems in terms of poor clinical outcomes, reduced quality of life and economic burdens. It is therefore imperative to comprehend the impact of all One Health domains, such as humans, livestock, agriculture and ecosystems in the fight against AMR. This narrative review therefore aims to highlight the resistance mechanisms, AMR global burden and its contributing factors. Additionally, this review identifies currently existing information gaps, monitoring parameters and global AMR mitigation strategies.MethodsA structured literature search was conducted across multiple electronic databases, including PubMed, EMBASE, ScienceDirect, the Cochrane Library, and Google Scholar to identify relevant peer-reviewed studies on antimicrobial resistance (AMR). The search included articles published in English between January 2013 and January 2025. Additional references were identified through manual screening of reference lists and relevant global reports from organizations such as the World Health Organization (WHO) and the Global Antimicrobial Resistance and Use Surveillance System (GLASS). Studies were eligible for inclusion if they addressed AMR in human health, animal health, agriculture, food systems and environmental settings within a One Health framework with particular emphasis on low- and middle-income countries (LMICs) as classified by the World Bank. Articles focusing on AMR mechanisms, transmission pathways, surveillance systems, AMS, environmental dissemination, and public health consequences were considered for inclusion.ResultsThe review narrative identified five major themes: global AMR burden, resistance mechanisms, cross-sectoral drivers, surveillance gaps, and stewardship responses. Globally, AMR was linked to 4.95 million deaths in 2019, with 3.57 million deaths directly attributable to drug-resistant infections. The major pathogens included Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus, which exhibited alarming resistance to last-line antibiotics. The overuse of antibiotics in healthcare and agriculture, poor sanitation, unchecked use of biocides and heavy metals, and weak AMR surveillance were identified as the principal drivers. Data from the WHO’s Global Antimicrobial Resistance Surveillance System (GLASS) confirmed the escalation of resistance among priority pathogens.ConclusionAMR is a multifaceted One Health challenge that requires urgent and integrated efforts to be mitigated. Strengthening integrated One Health surveillance, AMS, wastewater monitoring, and LMIC laboratory capacity should become immediate global policy priorities. Without immediate and sustained interventions, AMR threatens to reverse decades of medical progress and compromise the achievement of global health objectives. AMR is spreading globally due to irrational (un-judicious) antimicrobial use, cross-sectoral contamination, and the genetic exchange of resistance determinants among bacterial populations. Resistance gene transfer, particularly via horizontal mechanisms, is most pronounced where human, livestock, and environmental (One Health) interfaces overlap.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.